Status:
COMPLETED
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
Lead Sponsor:
ARCA Biopharma, Inc.
Collaborating Sponsors:
Premier Research
Conditions:
Arterial Occlusive Diseases
Peripheral Vascular Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This trial is for patients with acute occlusion of one of the arteries supplying blood to the leg. The trial is designed to determine the safety and activity of a novel clot dissolving (thrombolytic) ...
Eligibility Criteria
Inclusion
- Patients with acute peripheral arterial occlusion of the lower limb (onset of symptoms within 14 days)
- Rutherford Class I or IIa (minimal sensory loss, no muscle weakness, audible venous flow)
- Age 18 or above
- Able to consent
- Able to follow up
Exclusion
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00073554
Start Date
June 1 2003
Last Update
December 17 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic Foundation
Cleveland, Ohio, United States